Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors
Docking (animal)
Linker
DOI:
10.1016/j.ejmcr.2022.100034
Publication Date:
2022-02-10T03:01:22Z
AUTHORS (9)
ABSTRACT
COVID-19 is a global pandemic caused by infection with the SARS-CoV-2 virus. Remdesivir, RNA polymerase inhibitor, only drug to have received widespread approval for treatment of COVID-19. The main protease enzyme (M
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (87)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....